MARKET

SLNO

SLNO

SOLENO THERAPEUT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.550
+0.010
+0.65%
Opening 12:24 11/14 EST
OPEN
1.550
PREV CLOSE
1.540
HIGH
1.564
LOW
1.513
VOLUME
11.26K
TURNOVER
--
52 WEEK HIGH
5.07
52 WEEK LOW
1.110
MARKET CAP
69.18M
P/E (TTM)
-2.4737
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SLNO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SLNO News

  • Soleno Therapeutics EPS beats by $0.20
  • seekingalpha.23h ago
  • Soleno Therapeutics Q3 EPS $0.03 Up From $(0.11) YoY
  • Benzinga.1d ago
  • Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
  • GlobeNewswire.1d ago
  • 3 Small Biotech Stocks Insiders Are Buying
  • Seeking Alpha - Article.11/04 15:56

More

Industry

Medical Equipment, Supplies & Distribution
+0.12%
Healthcare Equipment & Supplies
+0.14%

Hot Stocks

Name
Price
%Change

About SLNO

Soleno Therapeutics, Inc., formerly Capnia, Inc., is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief. The Company has developed the CoSense End-Tidal Carbon Monoxide Monitor that measures ETCO for the detection of dangerous hemolysis rates. The Infant Solutions product line, including the NeoPIP Infant Resuscitator Unit and accessories, is designed for controlled and accurate resuscitation of neonates and infants in the clinical environment. Serenz Nasal Relief is a hand-held nasal irrigator that uses carbon dioxide (CO2) gas to wash the nasal passages.
More

Webull offers Soleno Therapeutics Inc (SLNO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.